Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro (tirzepatide) does not directly cause dehydration, but it can raise your risk of becoming dehydrated indirectly. The GI side effects common in the early weeks (nausea, vomiting, and diarrhoea) mean some people lose more fluid than usual, particularly after a dose increase. Dehydration is a real consideration on this treatment, even if the medicine itself isn't stripping water from your body. Mounjaro is a prescription-only medicine; a prescriber will weigh up your individual situation before treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A question our prescribers hear fairly often goes something like this: "I've read Mounjaro dries you out, is it diuretic?" It's an easy assumption to make, and it's worth putting to rest gently. Tirzepatide is not a diuretic. It doesn't act on the kidneys to increase urine output, and it doesn't draw fluid out of your cells. If you look at how the medicine actually works (as a dual GIP and GLP-1 receptor agonist that slows gastric emptying and reduces appetite) there's no mechanism there that would directly lower your body's fluid levels.
What does happen is more indirect, and arguably more manageable once you understand it. The NHS medicines page for tirzepatide lists nausea, vomiting, and diarrhoea as common side effects, particularly in the early stages of treatment. Any of those, if significant, will cost you fluid. That's the actual dehydration risk, not the medicine itself, but the body's GI response to it.
So no, Mounjaro does not dehydrate you at a cellular level. But that doesn't mean dehydration is off the table as a concern, and ignoring fluid intake on this treatment would be a mistake.
Here's something that catches people out: appetite suppression doesn't just reduce how much you eat. Hunger and thirst are physiologically intertwined, and when appetite falls sharply, the impulse to drink often fades with it. Many people starting Mounjaro report that they simply forget to drink. They feel less hungry, they eat smaller portions, and water intake slides without any obvious warning sign until a headache or dizziness arrives mid-afternoon.
Food itself accounts for roughly 20–30% of daily fluid intake for most people. If you're eating considerably less, that contribution disappears. Couple that with GI symptoms, and fluid balance can shift in ways that explain why Mounjaro causes dehydration concerns for some users more than you'd expect.
The practical answer is deliberate hydration: sipping water consistently across the day rather than relying on thirst as the prompt. This matters more during the first few months when GI side effects are most common, and again whenever your dose increases. There's also some evidence that staying well-hydrated helps moderate GI symptoms themselves, making this one of the more self-reinforcing habits you can build on treatment. For a broader look at how tirzepatide behaves in the body, the tirzepatide overview covers the mechanism in more depth. If bloating is also something you've noticed alongside changes in thirst, that's a separate but related pattern worth reading about via our page on bloating and Mounjaro.
Most nausea and loose stools on Mounjaro are self-limiting. They peak in the first one to two weeks at a given dose and settle for the majority of people. Mild dehydration during that window (feeling a bit dry-mouthed, darker urine) can usually be managed by drinking more and eating smaller, lower-fat meals that are gentler on a slowed gut.
Persistent or severe vomiting and diarrhoea is a different situation. If you can't keep fluids down, dehydration can develop quickly and, if prolonged, puts strain on the kidneys. The MHRA's Yellow Card scheme exists partly for this kind of reporting, and it's worth knowing about. But in the immediate term, if symptoms are severe enough that rehydration at home feels impossible, you should contact your GP or NHS 111, not wait for your next prescription review.
Signs that warrant prompt attention include dizziness on standing, passing very little urine, rapid heartbeat, or confusion. None of these are typical of the GI adjustment period; they suggest you need assessment and possibly fluid support.
People who are older, take other medicines that affect kidney function, or have a history of kidney problems should discuss hydration management with their prescriber before starting treatment. That conversation happens at the consultation stage. Questions about the cost of starting treatment are covered separately on our Mounjaro pricing page, where we also explain what a legitimate private prescription includes. For a detailed look at how dehydration and tirzepatide interact as a clinical question, our page on tirzepatide and dehydration goes further. And if you're reading this because you're already on treatment and worried, our support team is available seven days a week.
If you're considering starting Mounjaro and want your individual health picture assessed by a real clinician, start your free consultation with nume, a GPhC-registered prescriber will review your answers the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.